Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) saw a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 100 shares, a decline of 80.0% from the October 15th total of 500 shares. Based on an average daily volume of 8,700 shares, the short-interest ratio is presently 0.0 days.

Hedge Funds Weigh In On Intelligent Medicine Acquisition

A hedge fund recently raised its stake in Intelligent Medicine Acquisition stock. Periscope Capital Inc. lifted its holdings in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) by 103.3% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 714,454 shares of the company's stock after acquiring an additional 363,054 shares during the period. Periscope Capital Inc.'s holdings in Intelligent Medicine Acquisition were worth $67,000 at the end of the most recent quarter.

Intelligent Medicine Acquisition Price Performance

IQMDW traded down $0.03 on Friday, hitting $0.03. The company had a trading volume of 32,648 shares, compared to its average volume of 15,736. The company has a fifty day simple moving average of $0.06. Intelligent Medicine Acquisition has a 12-month low of $0.01 and a 12-month high of $0.60.

About Intelligent Medicine Acquisition

Intelligent Medicine Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.

See Also

• Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDW)
• Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
• Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
• Six Flags is a Ride You Don't Want to Get Stuck On
• Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
• Hanesbrands May be Signaling a Bad Week for Retail Stocks

Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.